切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2023, Vol. 17 ›› Issue (01) : 1 -5. doi: 10.3877/cma.j.issn.1674-1358.2023.01.001

综述

系统性红斑狼疮合并活动性结核病研究进展
马亚楠1, 侍效春2, 刘晓清3,()   
  1. 1. 100730 北京,中国医学科学院北京协和医学院,北京协和医院,疑难重症及罕见病国家重点实验室,感染内科
    2. 100730 北京,中国医学科学院北京协和医学院,北京协和医院,疑难重症及罕见病国家重点实验室,感染内科;100730 北京,中国医学科学院北京协和医学院,结核病研究中心
    3. 100730 北京,中国医学科学院北京协和医学院,北京协和医院,疑难重症及罕见病国家重点实验室,感染内科;100730 北京,中国医学科学院北京协和医学院,结核病研究中心;100730 北京,中国医学科学院北京协和医学院,国际临床流行病学网,临床流行病学教研室
  • 收稿日期:2022-07-27 出版日期:2023-02-15
  • 通信作者: 刘晓清
  • 基金资助:
    "十二五"国家科技重大专项(No. 2014ZX10003003); "十三五"国家科技重大专项(No. 2017ZX10201302-003); 中国医学科学院医学与健康科技创新工程项目(No. 2016-I2M-1-013、2019-I2M-2-005)

Research progress on systemic lupus erythematosus compicated with active tuberculosis

Yanan Ma1, Xiaochun Shi2, Xiaoqing Liu3,()   

  1. 1. Division of Infectious Diseases, Department of Internal Medicine, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
    2. Division of Infectious Diseases, Department of Internal Medicine, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
    3. Division of Infectious Diseases, Department of Internal Medicine, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Clinical Epidemiology Unit, Peking Union Medical College, International Clinical Epidemiology Network, Beijing 100730, China
  • Received:2022-07-27 Published:2023-02-15
  • Corresponding author: Xiaoqing Liu
引用本文:

马亚楠, 侍效春, 刘晓清. 系统性红斑狼疮合并活动性结核病研究进展[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(01): 1-5.

Yanan Ma, Xiaochun Shi, Xiaoqing Liu. Research progress on systemic lupus erythematosus compicated with active tuberculosis[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(01): 1-5.

系统性红斑狼疮(SLE)是一种多器官多系统受累的慢性自身免疫性疾病。感染是导致SLE患者发病和死亡最常见的原因之一。与普通人群相比,SLE患者感染事件发生风险显著增加。其中,活动性结核病(ATB)作为单一传染性疾病的重要死因,与SLE间的相互作用较为复杂。一方面SLE患者因本身免疫功能异常及激素和免疫抑制剂的使用,更易发生结核病;另一方面,结核分枝杆菌感染诱发的免疫激活又是SLE发生发展的危险因素之一,两者互为因果。当SLE患者并发ATB时,临床症状往往不典型,很难与SLE本身活动或其他感染相鉴别,易造成漏诊及误诊;且病情重,发生播散性肺结核及肺外结核比例显著升高。本文就SLE患者发生ATB的临床特点进行综述,为更好地认知SLE合并ATB提供一定依据。

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease, characterized by a multitude of autoantibodies and multiorgan damage. Infections are the most common causes of the morbidity and mortality of patients with SLE. The risk of infection in SLE patients is significantly higher than the general population. Active tuberculosis (ATB), as a single infectious etiology of death, has a complex relationship with SLE. On the one hand, patients with SLE always increased the susceptibility to tuberculosis due to autoimmune disorder and the use of glucocorticoids and immunosuppressants. On the other hand, immune activation induced by tuberculosis infection can predispose patients to the occurrence and development of SLE; the two causes interact as both cause and effect. When patients with SLE are complicated with ATB, the clinical symptoms are often atypical, and it is difficult to distinguish it from SLE itself or other infections, which is easy to cause missed diagnosis and misdiagnosis, and the disease is serious, and the proportion of disseminated tuberculosis and extrapulmonary tuberculosis increased significantly. This paper reviews the clinical characteristics of ATB of patients with SLE, which provides some basis for better cognition of SLE complicated with ATB in clinical practice.

表1 系统性红斑狼疮合并结核病的主要研究
表2 系统性红斑狼疮预防性抗结核治疗的主要研究
[1]
World Health Organization. Global tuberculosis report 2021[EB/OL]. World Health Organization2021.

URL    
[2]
Oku K, Hamijoyo L, Kasitanon N, et al. Prevention of infective complications in systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements[J]. Int J Rheum Dis,2021,24(7):880-895.
[3]
Pego-Reigosa JM, Nicholson L, Pooley N, et al. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis[J]. Rheumatology (Oxford),2021,60(1):60-72.
[4]
Barber MRW, Clarke AE. Systemic lupus erythematosus and risk of infection[J]. Expert Rev Clin Immunol,2020,16(5):527-538.
[5]
穆克利. 系统性红斑狼疮患者感染结核分枝杆菌后血清免疫指标变化及临床意义 [J/CD]. 中华实验和临床感染病杂志(电子版),2014,8(5):627-630.
[6]
Doaty S, Agrawal H, Bauer E, et al. Infection and lupus: which causes which?[J]. Curr Rheumatol Rep,2016,18(3):13.
[7]
González-Naranjo LA, Coral-Enríquez JA, Restrepo-Escobar M, et al. Factors associated with active tuberculosis in Colombian patients with systemic lupus erythematosus: a case-control study[J]. Clin Rheumatol,2021,40(1):181-191.
[8]
Askanase AD, Yazdany J, Molta CT. Post-marketing experiences with belimumab in the treatment of SLE patients[J]. Rheum Dis Clin North Am,2014,40(3):507-17, viii.
[9]
Felten R, Dervovic E, Chasset F, et al. The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trials[J]. Autoimmun Rev,2018,17(8):781-790.
[10]
全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告[J]. 中国防痨杂志,2012,34(8):485-508.
[11]
Liu X, Zhang L, Zhang F, et al. Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China[J]. Emerg Microbes Infect,2021,10(1):2303-2312.
[12]
Xiao X, Da G, Xie X, et al. Tuberculosis in patients with systemic lupus erythematosus-a 37-year longitudinal survey-based study[J]. J Intern Med,2021,290(1):101-115.
[13]
Lao M, Chen D, Wu X, et al. Active tuberculosis in patients with systemic lupus erythematosus from Southern China: a retrospective study[J]. Clin Rheumatol,2019,38(2):535-543.
[14]
Muhammed H, Jain A, Pattanaik SS, et al. Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus[J]. Rheumatol Int,2021,41(12):2185-2193.
[15]
Hamijoyo L, Candrianita S, Rahmadi A R, et al. The clinical characteristics of systemic lupus erythematosus patients in Indonesia: a cohort registry from an Indonesia-based tertiary referral hospital[J]. Lupus,2019,28(13):1604-1609.
[16]
Cheng CF, Huang YM, Lu CH, et al. Prednisolone dose during treatment of tuberculosis might be a risk factor for mortality in patients with systemic lupus erythematosus: a hospital-based cohort study[J]. Lupus,2019,28(14):1699-1704.
[17]
Greenstein L, Makan K, Tikly M. Burden of comorbidities in South Africans with systemic lupus erythematosus[J]. Clin Rheumatol,2019,38(8):2077-2082.
[18]
Yang Y, Thumboo J, Tan BH, et al. The risk of tuberculosis in SLE patients from an Asian tertiary hospital[J]. Rheumatol Int,2017,37(6):1027-1033.
[19]
中华人民共和国国家卫生和计划生育委员会. 肺结核诊断标准(WS 288-2017)[J/CD]. 新发传染病电子杂志,2018,3(1):59-61.
[20]
Sargin G, Senturk T, Ceylan E, et al. TST, QuantiFERON-TB Gold test and T-SPOT. TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy[J]. Tuberk Toraks,2018,66(2):136-143.
[21]
边赛男, 刘晓清. γ-干扰素释放试验在免疫功能抑制人群中诊断结核分枝杆菌感染的应用[J/CD]. 中华实验和临床感染病杂志(电子版)2017,11(2):117-120.
[22]
Zhang L, Zhang Y, Shi X, et al. Utility of T-cell interferon-gamma release assays for diagnosing tuberculous serositis: a prospective study in Beijing, China[J]. PLoS One,2014,9(1):e85030.
[23]
Palavutitotai N, Buppajarntham T, Katchamart W. Etiologies and outcomes of pleural effusions in patients with systemic lupus erythematosus[J]. J Clin Rheumatol,2014,20(8):418-421.
[24]
Chen DY, Huang YH, Chen YM, et al. ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies[J]. Lupus Sci Med,2021,8(1):e000562.
[25]
Silva JE, Silva C, Pacheco M, et al. Simultaneous systemic lupus erythematosus flare and disseminated tuberculosis: Balancing anti-mycobacterial and autoimmune treatments[J]. Cureus,2021,13(10):e18944.
[26]
World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management[M]. Geneva, 2018.
[27]
国家卫生健康委员会办公厅. 国家卫生健康委办公厅关于印发中国结核病预防控制工作技术规范(2020年版)的通知[EB/OL]. (2020-04-02) [2020-06-10].

URL    
[28]
中国防痨协会. 高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识[J]. 中国防痨杂志,2021,43(9):874-878.
[29]
Gaitonde S, Pathan E, Sule A, et al. Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment [J]. Ann Rheum Dis,2002,61(3):251-253.
[30]
马丽, 林冰, 王丽英, 等. 预防治疗系统性红斑狼疮患者医源性活动性结核病的临床观察 [J]. 中华医学杂志,2014,45(4):3579-3582.
[31]
Mok MY, Lo Y, Chan TM, et al. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy[J]. J Rheumatol,2005,32(4): 609-615.
[32]
谢其冰, 尹耕. 应用异烟肼预防系统性红斑狼疮患者结核感染的作用评估[J]. 四川大学学报(医学版),2008,39(3):519-520.
[33]
赵利军, 刘桂枝. 异烟肼预防系统性红斑狼疮患者结核感染的临床分析[J]. 世界最新医学信息文摘,2015,15(98):74-75.
[1] 李培杰, 乔永杰, 张浩强, 曾健康, 谭飞, 李嘉欢, 王静, 周胜虎. 细菌培养阴性的假体周围感染诊治的最新进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 827-833.
[2] 涂家金, 廖武强, 刘金晶, 涂志鹏, 毛远桂. 严重烧伤患者鲍曼不动杆菌血流感染的危险因素及预后分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 491-497.
[3] 廖锵云, 王震, 林洁玉, 廖夏, 邓锦华, 李杰峰, 邓建维, 李明, 荣新洲. 虎门地区创伤弧菌感染的临床观察[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 394-398.
[4] 蔡柔妹, 曾洁梅, 黄伟丽, 谢文敏, 刘燕丹, 吴漫君, 蔡楚燕. 利用QC小组干预降低经烧伤创面股静脉置管导管相关性感染发生率的临床观察[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 399-404.
[5] 杨瑞洲, 李国栋, 吴向阳. 腹股沟疝术后感染的治疗方法探讨[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 715-719.
[6] 徐金林, 陈征. 抗菌药物临床应用监测对腹股沟疝修补术预防用药及感染的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 720-723.
[7] 李静如, 王江玲, 吴向阳. 简易负压引流在腹股沟疝术后浅部感染中的疗效分析[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 745-749.
[8] 李秉林, 吕少诚, 潘飞, 姜涛, 樊华, 寇建涛, 贺强, 郎韧. 供肝灌注液病原菌与肝移植术后早期感染的相关性分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 656-660.
[9] 赵立力, 王魁向, 张小冲, 李志远. 血沉与C-反应蛋白比值在假体周围感染中的诊断价值分析[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 351-355.
[10] 卓少宏, 林秀玲, 周翠梅, 熊卫莲, 马兴灶. CD64指数、SAA/CRP、PCT联合检测在小儿消化道感染性疾病鉴别诊断中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 505-509.
[11] 李静静, 翟蕾, 赵海平, 郑波. 多囊肾合并囊肿的多重耐药菌感染一例并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(08): 920-923.
[12] 李达, 张大涯, 陈润祥, 张晓冬, 黄士美, 陈晨, 曾凡, 陈世锔, 白飞虎. 海南省东方市幽门螺杆菌感染现状的调查与相关危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 858-864.
[13] 卓徐鹏, 刘颖, 任菁菁. 感染性疾病与老年人低蛋白血症的相关性研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 896-899.
[14] 李琪, 黄钟莹, 袁平, 关振鹏. 基于某三级医院的ICU多重耐药菌医院感染影响因素的分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 777-782.
[15] 杨艳丽, 陈昱, 赵若辰, 杜伟, 马海娟, 许珂, 张莉芸. 系统性红斑狼疮合并血流感染的危险因素及细菌学分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 694-699.
阅读次数
全文


摘要